Fragile X syndrome: Prevalence, treatment, and prevention in China

Manman Niu, Ying Han, Angel Belle C. Dy, Junbao Du, Hongfang Jin, Jiong Qin, Jing Zhang, Qinrui Li, Randi J Hagerman

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and the leading monogenic cause of autism spectrum disorder. Although FXS has been studied for several decades, there is relatively little basic science or clinical research being performed on FXS in China. Indeed, there is a large gap between China and Western countries in the FXS field. China has a potentially large number of FXS patients. However, many of them are underdiagnosed or even misdiagnosed, and treatments are not always administered in the Chinese population. This review discusses the prevalence, treatment, and prevention of FXS in China to facilitate an understanding of this disease in the Chinese population.

Original languageEnglish (US)
Article number254
JournalFrontiers in Neurology
Volume8
Issue numberJUN
DOIs
StatePublished - Jun 6 2017

Keywords

  • China
  • Fragile X syndrome
  • Prevalence
  • Prevention
  • Treatment

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Fragile X syndrome: Prevalence, treatment, and prevention in China'. Together they form a unique fingerprint.

  • Cite this

    Niu, M., Han, Y., Dy, A. B. C., Du, J., Jin, H., Qin, J., Zhang, J., Li, Q., & Hagerman, R. J. (2017). Fragile X syndrome: Prevalence, treatment, and prevention in China. Frontiers in Neurology, 8(JUN), [254]. https://doi.org/10.3389/fneur.2017.00254